594 reports of this reaction
4.0% of all DEXTROMETHORPHAN reports
#4 most reported adverse reaction
OVERDOSE is the #4 most commonly reported adverse reaction for DEXTROMETHORPHAN, manufactured by RB Health (US) LLC. There are 594 FDA adverse event reports linking DEXTROMETHORPHAN to OVERDOSE. This represents approximately 4.0% of all 14,865 adverse event reports for this drug.
Patients taking DEXTROMETHORPHAN who experience overdose should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OVERDOSE is moderately reported among DEXTROMETHORPHAN users, representing a notable but not dominant share of adverse events.
In addition to overdose, the following adverse reactions have been reported for DEXTROMETHORPHAN:
The following drugs have also been linked to overdose in FDA adverse event reports:
OVERDOSE has been reported as an adverse event in 594 FDA reports for DEXTROMETHORPHAN. This does not prove causation, but indicates an association observed in post-market surveillance data.
OVERDOSE accounts for approximately 4.0% of all adverse event reports for DEXTROMETHORPHAN, making it a notable side effect.
If you experience overdose while taking DEXTROMETHORPHAN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.